Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: To investigate the efficacy and safety of repurposed antiprotozoal and antiretroviral drugs, nitazoxanide and atazanavir/ritonavir, in shortening the time to clinical improvement and achievement of SARS-CoV-2 polymerase chain reaction (PCR) negativity in patients diagnosed with moderate...

Descripción completa

Detalles Bibliográficos
Autores principales: Olagunju, Adeniyi, Fowotade, Adeola, Olagunoye, Ajibola, Ojo, Temitope Olumuyiwa, Adefuye, Bolanle Olufunlola, Fagbamigbe, Adeniyi Francis, Adebiyi, Akindele Olupelumi, Olagunju, Omobolanle Ibitayo, Ladipo, Olabode Taiwo, Akinloye, Abdulafeez, Adeagbo, Babatunde Ayodeji, Onayade, Adedeji, Bolaji, Oluseye Oladotun, Happi, Christian, Rannard, Steve, Owen, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780204/
https://www.ncbi.nlm.nih.gov/pubmed/33397457
http://dx.doi.org/10.1186/s13063-020-04987-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780204/
https://www.ncbi.nlm.nih.gov/pubmed/33397457
http://dx.doi.org/10.1186/s13063-020-04987-8

Ejemplares similares